fructose 2,6-diphosphate has been researched along with Diabetes Mellitus in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, T; Horikoshi, H; Okuno, A; Yoshioka, S | 1 |
| Beliaeva, NF; Golubev, MA; Gorodetskiĭ, VK; Korovkin, BF; Markova, MS; Saiapin, AV; Stvolinskaia, NS; Viktorova, LN | 1 |
| Balabolkin, MI; Beliaeva, NF; Golubev, MA; Gorodetskiĭ, VK; Kol'chenko, OL; Korovkin, BF; Lamzina, NN; Markova, MS; Viktorova, LN | 1 |
| Leahy, JL; Liu, YQ; Tornheim, K | 1 |
| Bartrons, R; Lange, AJ; Manzano, A; Navarro-Sabatè, A; Okar, DA; Riera, L | 1 |
2 review(s) available for fructose 2,6-diphosphate and Diabetes Mellitus
| Article | Year |
|---|---|
[The fructose-2,6-diphosphate system and diabetes mellitus].
Topics: Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Fructosediphosphates; Humans | 1994 |
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate.
Topics: Animals; Diabetes Mellitus; Evolution, Molecular; Forecasting; Fructosediphosphates; Humans; Isoenzymes; Liver; Phosphofructokinase-2; Phosphoric Monoester Hydrolases; Protein Conformation | 2001 |
3 other study(ies) available for fructose 2,6-diphosphate and Diabetes Mellitus
| Article | Year |
|---|---|
Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice.
Topics: Animals; Chromans; Diabetes Mellitus; Fructose-Bisphosphatase; Fructosediphosphates; Gluconeogenesis; Glycolysis; Hypoglycemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Phosphofructokinase-1; Reference Values; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone | 1995 |
[Determination of fructose-2,6-biphosphate in human peripheral blood lymphocytes--a potential clinico-laboratory test in diabetology].
Topics: Diabetes Mellitus; Fructosediphosphates; Humans; Lymphocytes; Reference Values | 1996 |
Fatty acid-induced beta cell hypersensitivity to glucose. Increased phosphofructokinase activity and lowered glucose-6-phosphate content.
Topics: Allosteric Regulation; Animals; Coenzyme A Ligases; Diabetes Mellitus; Drug Interactions; Fructosediphosphates; Glucose; Glucose-6-Phosphate; Insulin; Insulin Secretion; Islets of Langerhans; Oleic Acid; Oxidation-Reduction; Pentose Phosphate Pathway; Phosphofructokinase-1; Rats; Rats, Sprague-Dawley; Repressor Proteins; Saccharomyces cerevisiae Proteins; Triazenes | 1998 |